Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No way to tell that I'm aware of.
Hopefully there won't be a need to do more financing. We could be on the market with a couple different products in months, whomever it is, is playing the odds that we will need more financing. If we get the European market for AXAL, look for a massive run up just off of short covering!
Waiting on capital gains on their short and for Dan to supply them with shares to cover.
I'm with you, hopefully my funds I'm moving will arrive this week and I'll be able to get more at this price. I really don't expect our SP to linger here too much longer.
Yeah, waiting on some funds I had transferred from Vanguard to my IRA to be deposited and I'll be taking another bite out of this peach. I've actually been hoping they would hold it down for a little while longer.
It's all good, we're being held down so the weak can be picked off!
I agree. There will be a binary event at some point here.
Compassionate use for advaxis should put Aduro's share price through the roof, ha ha!
I am in the process of transferring some funds that I had forgotten about to buy a few more thousand shares of advaxis. I've been invested here eight years and have never been more confident. Lead don't follow friends!
I noticed that, I think the classification they gave us puts us in a completely different lot of medical therapies that can be brought to market a lot sooner. There's definitely enough safety data to look at.
That does speak volumes.
Thats awesome James. I really think after the PR the other day we will have a product on the market in Europe a lot sooner then any of us anticipated.
I don't think we will get passed up, we're probably decade ahead of the pack in science and efficacy. We can undercut anybody price wise and still make a killing in the process. Absolutely no weaknesses with this little Bio!
The ATMP designation is a classification for certain medicines for human use that are gene-, cell-, or tissue-based. The main responsibility of the CAT is to prepare a draft opinion on each ATMP application submitted to the European Medicines Agency, before the Committee for
This statement from the PR leads me to believe that we are being classified differently then most drugs greatly reducing our time to market in Europe!
Things are a little different in Europe, AXAL could wind up on the market over there real soon. The only option shorts have is to try and scare the unintelligent retail out of their shares.
I agree, what a mess over there, nothing more then a tool for shorts to torture investors
Well, I hope you are right, it would make sense, wouldn't it.
It definitely has James, the news is making the FDA look silly as well.
I think the reasons for not making a deal prematurely for AXAL is starting to be made very clear.
The news should pull in some European investors as well. Today should be very interesting.
I totally agree James, it looks like they are gearing up for commercial production if we didn't know better.
I'm thinking this board might just be alright.
Hey hdwrsft, just got signed up over here, to heck with yhmb, finally got completely locked out!